• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Australia’s bumper earnings get Delta reality check

September 3, 2021 by David Barret Leave a Comment

September 3, 2021

By Paulina Duran

SYDNEY (Reuters) – An Australian earnings season bonanza for shareholders has masked a more uncertain outlook for the corporate sector as the Delta COVID variant threatens to tip an economy that was surging only months ago back into its second recession in as many years.

Australian-listed companies delivered a record A$38 billion ($28 billion) in promised dividends to investors in the season that ended this week, driven by banks and mining companies.

However, when it came to the corporate outlook, companies had much less cheer to offer.

“Companies really pulled back on giving outlook statements given the uncertainties,” said Brad Potter, the head of Australian Equities at Tyndall Asset Management.

“I think the resilience of the economy has been amazing but given the situation that we’re in, I don’t think anyone is particularly bullish.”

Earnings reported by Australia’s top 200 companies in August for the 2021 year came in slightly above expectations, Eikon data shows, even as COVID-19 threw most of the country into lockdown.

However, with the Delta variant and declines in commodity prices from record highs threatening to tip the economy into a recession, buy-side analysts and investors have downgraded earnings and dividend forecasts.

Following a whopping 37% increase in aggregate reported earnings by the 156 companies covered by Citigroup in fiscal 2021, the broker cut its forecast for fiscal 2022 by 2.9% to A$124 billion.

That included a cut of about 5% for the banking sector, due to soft core earnings prospects and about 4% for mining companies, driven by sharp falls in iron ore prices. [IRONORE/]

Dividend consensus expectations for the year also fell by about 3.1%, according to JPMorgan.

“It does seem that the upward revision momentum in the near term has slowed down,” Credit Suisse portfolio manager Mike Jenneke said.

That would still leave a very robust expectation of 16% growth in earnings by Citi this fiscal year, as vaccination rates amongst 25 million Australians increase, and pent-up demand drives an earnings rebound in the second half, particularly in the financials, materials and consumer discretionary sectors.

By comparison, Reuters data showed profits at U.S. firms are estimated to decline 7.2% in the third quarter, after rising 12.4% in the second quarter.

On a calendar year basis, global earnings are expected to grow 8% in 2022, after a 46% jump in 2021, according to Credit Suisse.

In Australia, over A$18 billion worth of share buybacks have been announced on top of the 80% jump in dividends declared during the reporting season, while record M&A is expected to deliver an extra windfall.

“There’s a whole lot of cash that is going to be hitting investor’s bank accounts over the next few months from those dividends,” said Hugh Dive, Atlas Funds Management Chief Investment Officer.

“Looking ahead is a bit uncertain, even for the companies that have done very well and are tracking very strong numbers, it’s going to be difficult for them to keep going.”

Diagnostics firm Sonic Healthcare, whose profit more than doubled to A$1.3 billion, declined to provide earnings guidance saying the pandemic had the “potential to cause fluctuations in both COVID-19 testing revenues and the base business”.

Others withholding explicit earnings guidance included hospital owner Ramsay Healthcare, retailer Coles Group and waste management firm Cleanaway Waste Management.

($1 = 1.3541 Australian dollars)

(Reporting by Paulina Duran in Sydney; Editing by Sam Holmes)

Source Link Australia’s bumper earnings get Delta reality check

David Barret
David Barret

Related posts:

  1. “Our Mikis has gone”: ‘Zorba the Greek’ composer Theodorakis dies at 96
  2. WTO chief seeks fishing, pandemic accords by year end
  3. 5 Star Wars games we’d love to see on PC
  4. Amazon Labor Day sales 2021: the best early deals

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Alien Abduction Or A Trick Of The Mind? A Down To Earth Explanation Of Close Encounters
  • Six Months Into Trump’s Presidency, Americans Report Record Low Pride In Being American
  • TikToker Unknowingly Handles Extremely Venomous Cone Snail And Lives To Tell The Tale
  • Scientists Sequence Oldest Egyptian DNA To Date, From A Whopping 4,800 Years Ago
  • “Uncharted Waters”: Large Hadron Collider Begins Colliding Oxygen For The First Time
  • 125,000-Year-Old Neanderthal “Fat Factory” Shows They Gorged On Bone Grease
  • On July 3, Earth Will Reach Its Farthest Point From The Sun – 152 Million Kilometers Away
  • NASA’s Perseverance Rover May Have Recorded Evidence Of Electrified Dust Devils On Mars
  • “Hymn to Babylon”: Missing Mesopotamian Text Dating Back Nearly 3,000 Years Discovered
  • Multiple New Species Of Cute Spotty And Stripy Geckos Discovered In Remote Cambodia
  • ChatGPT May Be Surprisingly Good At Piloting Spacecraft, Taking 2nd Place In Spaceflight Competition
  • Incredible Supernova Finding Shows That “Double-Detonation Mechanism” Happens In Nature
  • Soda Cans, Asthma Inhalers, And… Water Bottles? All Things That Could Explode In Your Car This Summer
  • Video: Is There An Ideal Sleeping Position?
  • If You Look Up At The Right Time Today, You Will See A Giant “X” On The Moon
  • We May Have Our Third Interstellar Visitor And It’s Nothing Like The Previous Two
  • Orcas Filmed Kissing (With Tongues) In The Wild For The First Time
  • How Easy Is It For A Country To Change Its Time Zone?
  • Earth’s First Commercial Space Station Set To Launch In 2026
  • Black Hole Moon: Rogue Planets With Weird Signatures Could Be A Sign Of Advanced Alien Life
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version